PMID- 20063872 OWN - NLM STAT- MEDLINE DCOM- 20100427 LR - 20100128 IS - 1520-5207 (Electronic) IS - 1520-5207 (Linking) VI - 114 IP - 4 DP - 2010 Feb 4 TI - Endogenous nonionic saturated monoethanolamide lipids: solid state, lyotropic liquid crystalline, and solid lipid nanoparticle dispersion behavior. PG - 1729-37 LID - 10.1021/jp910578h [doi] AB - The n-acylethanolamides (NAEs) are a family of naturally occurring monoethanolamide containing lipids that display a variety of interesting biological properties. In this study, some physicochemical properties of a series of saturated monoethanolamide lipids with increasing hydrocarbon chain length (lauroyl, myristoyl, palmitoyl, and stearoyl) have been investigated. Temperature induced phase transitions for these NAEs indicate that both the monoethanolamide headgroups and the unsaturated hydrophobic tails play a role in the melting behavior of these lipids. All four lipids examined demonstrate the presence of at least three different polymorphic crystal forms. Transitions in crystal structure can be induced via heating and visualized with polarized optical microscopy. At room and physiological temperature, the four NAEs are solid lamellar crystalline materials. All four molecules form lyotropic liquid crystalline phases in water, albeit at relatively high temperatures, including the lamellar liquid crystalline phase and at least two isotropic phases. Lamellar crystalline palmitoyl monoethanolamide was dispersed as solid lipid nanoparticles (SLNs). The cytotoxicity of these SLNs toward human mammary epithelial cells (HMEpiC) and the MCF7 breast cancer cell line was assessed at physiological temperature. The palmitoyl monoethanolamide SLNs showed little to no toxicity to the HMEpiC even at a concentration of 30 microM. At concentrations above 3 microM, the HMEpiC population was reduced by less than 15%, while the MCF7 population was reduced by approximately 20-30%. The endogenous nature and natural medicinal properties make this series of lipids ideal candidates for further investigation as solid lipid nanoparticle drug delivery systems. FAU - Sagnella, Sharon M AU - Sagnella SM AD - CSIRO Molecular and Health Technologies, P.O. Box 184, North Ryde, New South Wales 1670, Australia. FAU - Conn, Charlotte E AU - Conn CE FAU - Krodkiewska, Irena AU - Krodkiewska I FAU - Moghaddam, Minoo AU - Moghaddam M FAU - Drummond, Calum J AU - Drummond CJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Phys Chem B JT - The journal of physical chemistry. B JID - 101157530 RN - 0 (Amides) RN - 0 (Lipids) SB - IM MH - Amides/*chemistry MH - Calorimetry, Differential Scanning MH - Cell Line, Tumor MH - Humans MH - Lipids/*chemistry MH - Liquid Crystals/*chemistry MH - Nanoparticles/*chemistry/toxicity MH - Phase Transition MH - Transition Temperature EDAT- 2010/01/13 06:00 MHDA- 2010/04/28 06:00 CRDT- 2010/01/13 06:00 PHST- 2010/01/13 06:00 [entrez] PHST- 2010/01/13 06:00 [pubmed] PHST- 2010/04/28 06:00 [medline] AID - 10.1021/jp910578h [doi] PST - ppublish SO - J Phys Chem B. 2010 Feb 4;114(4):1729-37. doi: 10.1021/jp910578h.